Health

TGA dismisses bid to make contraceptive pill available over the counter in Australia

Two applications were made to amend poisons legislation so that the pill would not need ongoing prescriptions from doctor Download the free Guardian app; get our morning email briefing A push to make the contraceptive pill available over the counter has been dismissed by Australia’s drugs regulator. In an interim decision, now open for further …

TGA dismisses bid to make contraceptive pill available over the counter in Australia Read More »

Doctor who advocated Covid-19 therapy including ivermectin applied for patent on same unproven treatment

Exclusive: Australian professor Thomas Borody’s failure to widely declare that he could potentially profit from treatment he is promoting raises ethical concerns Get our free news app; get our morning email briefing A Sydney gastroenterologist who has been enthusiastically promoting an unapproved Covid-19 treatment, including to Australian politicians and general practitioners, has filed a patent …

Doctor who advocated Covid-19 therapy including ivermectin applied for patent on same unproven treatment Read More »

Local Covid vaccines fill gap as UN Covax scheme misses target

India, Egypt and Cuba among first states to develop and make their own vaccines as Covax falls behind Developing countries are increasingly turning to homegrown Covid vaccinations as the UN-backed Covax programme falls behind. While western countries roll out booster jabs to their own populations, Covax, which was set up by UN agencies, governments and …

Local Covid vaccines fill gap as UN Covax scheme misses target Read More »

WHO endorses use of world’s first malaria vaccine in Africa

World Health Organization’s director general hails ‘historic day’ in fight against parasitic disease The World Health Organization has recommended the widespread rollout of the first malaria vaccine, in a move experts hope could save tens of thousands of children’s lives each year across Africa. Hailing “an historic day”, the WHO’s director general, Dr Tedros Adhanom …

WHO endorses use of world’s first malaria vaccine in Africa Read More »

Covid antiviral pill halves hospitalisations and deaths, maker says

If approved, Merck’s drug would be first simple oral medication shown to be effective against coronavirus Coronavirus – latest updates See all our coronavirus coverage The first pill to treat coronavirus could be available within months after it was found to cut hospitalisations and deaths by half. If approved, the antiviral drug would be the …

Covid antiviral pill halves hospitalisations and deaths, maker says Read More »

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters

Fragmented care means patients can be put on drugs by many different specialists, says Charles Warlow, while Dr Wendy Outwin highlights the daily reality of prescribing medicines Ministers seem to have found yet another way to bash overburdened GPs (Government review finds 10% of drugs dispensed in England are pointless, 22 September). There is nothing …

Yes, drugs are overprescribed: but it’s not the fault of GPs | Letters Read More »

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty

Six companies warned not to put profit before lives as report shows less than 1% of almost 6bn doses have gone to low-income countries Amnesty International has accused six pharmaceutical companies that have developed Covid-19 vaccines of fuelling a global human rights crisis, citing their refusal to sufficiently waive intellectual property rights, share vaccine technology …

Big pharma fuelling human rights crisis over Covid vaccine inequity – Amnesty Read More »

Ministers told to bar EU from UK trial data in vaccines row

England’s deputy medical chief asked for data to be withheld unless British vaccine guinea pigs allowed to travel abroad • Coronavirus – latest updates• See all our coronavirus coverage England’s deputy chief medical officer asked ministers to withhold all UK clinical trial data from the EU if European countries continued to deny entry to British …

Ministers told to bar EU from UK trial data in vaccines row Read More »

UK cancels Covid vaccine deal with French firm Valneva

Government serves notice to terminate contract over allegations of a ‘breach of obligations’ Coronavirus – latest updates See all our coronavirus coverage The UK government is to pull out of a deal with the French pharmaceutical company Valneva to purchase its Covid-19 vaccination, the company has said. The move will come as a blow to …

UK cancels Covid vaccine deal with French firm Valneva Read More »

A year that changed the world – and medical companies’ fortunes

While Covid sent many firms to the wall, others prospered by spotting opportunities, from test kits to mask coatings The pandemic has taken a heavy toll on business, gutting high streets as familiar names fell into receivership. But for some less well-known firms, the past 18 months have been transformational. Those that have thrived did …

A year that changed the world – and medical companies’ fortunes Read More »

BioNTech to seek approval for Covid jabs for younger children

Company behind Pfizer vaccine expected to file results of trial of five- to 11-year-olds with regulator soon Coronavirus – latest updates See all our coronavirus coverage The German company BioNTech, which developed the Pfizer vaccine, expects to seek approval from regulators for Covid jabs suited for younger children as early as mid-October, its founders have …

BioNTech to seek approval for Covid jabs for younger children Read More »

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands

Leaked supply document reveals clauses to protect US pharma company from legal action in the event of serious side-effects Coronavirus – latest updates See all our coronavirus coverage Pfizer has been accused of holding Brazil “to ransom” over demands to shield itself from possible vaccine side-effect lawsuits in its contract to supply the country with …

Pfizer accused of holding Brazil ‘to ransom’ over vaccine contract demands Read More »

Australian Novavax trial participants remain unrecognised by vaccine register

Covid vaccination status of hundreds in limbo because the US company’s jab is yet to be approved in Australia Vaccine rollout tracker; get our free news app; get our morning email briefing Australians who participated in clinical trials of the Novavax Covid vaccine are being told their vaccinations cannot currently be recognised on Australia’s immunisation …

Australian Novavax trial participants remain unrecognised by vaccine register Read More »

UK approves rollout of ‘first of its kind’ Covid antibody treatment

Ronapreve can be used to treat symptoms of acute infection after successful clinical trials Coronavirus – latest updates See all our coronavirus coverage The medicines regulator has approved use of the first treatment in the UK using artificial antibodies to prevent and fight Covid-19. The health secretary, Sajid Javid, said approval of the first drug …

UK approves rollout of ‘first of its kind’ Covid antibody treatment Read More »

Drug firms poised to make billions of dollars from Covid booster jabs

Sales of BioNTech, Moderna and Pfizer drugs could rival $6bn-a-year market for flu vaccines, say analysts Coronavirus – latest updates See all our coronavirus coverage The drug companies Pfizer, BioNTech and Moderna are poised to make billions of dollars from Covid-19 booster jabs this autumn, with analysts estimating that sales could rival the $6bn-a-year market …

Drug firms poised to make billions of dollars from Covid booster jabs Read More »

Breast cancer drug approved for NHS after maker agrees discount

Reversal of earlier rejection by Nice of abemaciclib – known as Verzenios – is welcomed by campaigners A breast cancer drug that was rejected for routine NHS use in England earlier this year has now been recommended by health officials after a discount was agreed with the manufacturer. The decision has been described as “fantastic …

Breast cancer drug approved for NHS after maker agrees discount Read More »

UK orders extra Covid vaccines for autumn 2022 booster campaign

Pfizer reportedly asked to supply 35m more doses, with final go-ahead for this year’s programme still awaited Coronavirus – latest updates See all our coronavirus coverage Ministers have started ordering vaccines for a booster campaign in autumn 2022, with Pfizer reportedly being asked to supply the UK with a further 35m doses. The government has …

UK orders extra Covid vaccines for autumn 2022 booster campaign Read More »

Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs

Competition regulator the CMA alleges drugs firms abused dominant position with unfairly high prices Pharmaceutical companies Pfizer and Flynn have been accused by the UK’s competition watchdog of illegally overcharging the NHS for vital anti-epilepsy drugs by abusing their dominance in the market to raise prices overnight. The Competition and Markets Authority (CMA) has confirmed …

Pfizer and Flynn accused of overcharging NHS for anti-epilepsy drugs Read More »

Covid drug could help reduce heavy menstrual bleeding

Trial suggests anti-inflammatory dexamethasone may offer welcome alternative to intra-uterine system Researchers hope a steroid that shot to prominence during the Covid pandemic may help reduce blood loss in those who experience heavy periods. The cheap anti-inflammatory dexamethasone was discovered to improve survival rates among patients critically ill with Covid. It is also used for …

Covid drug could help reduce heavy menstrual bleeding Read More »

Drug firm that hiked prices by 6,000% paid shareholders £400m

Advanz Pharma and former private equity owners were fined £100m by markets watchdog A pharmaceuticals firm that inflated thyroid drug prices by up to 6,000% over a decade paid out more than £400m to shareholders and directors during the same period. London-based Advanz Pharma – and its former private equity owners HgCapital and Cinven – …

Drug firm that hiked prices by 6,000% paid shareholders £400m Read More »

Pain aggravation: the human cost of medicine price hikes

After Advanz’s £100m fine over the price of its thyroid tablets, two people recount the difficulty of obtaining medication The UK’s competition watchdog has fined pharmaceutical company Advanz over £100m for inflating the price of its thyroid tablets by up to 6,000%. The exorbitant costs resulted in NHS clinical commissioning groups advising doctors not to …

Pain aggravation: the human cost of medicine price hikes Read More »

Price gouging fine for Advanz is a rare story that is becoming common | Phillip Inman

Competition and Markets Authority is working on a string of cases involving the NHS being overcharged for drugs A fine by the Competition and Markets Authority (CMA) for unfair pricing by private health companies is a rare story that looks set to become increasingly common. This week’s example is the £100m penalty dished out to …

Price gouging fine for Advanz is a rare story that is becoming common | Phillip Inman Read More »

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021

Not-for-profit pledge sees British firm’s sales revenue fall significantly short of US rival Pfizer Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s Covid-19 vaccine has brought in $1.2bn (£900m) in the first half of this year, with sales tripling in the second quarter from the first – but its earnings remained significantly below …

AstraZeneca sales of Covid vaccine triple to $1.2bn in first half of 2021 Read More »

Pharma firm Advanz fined after thyroid drug price hike of 6,000%

CMA found company’s ‘excessive and unfair’ prices cost NHS almost £30m extra over 10 years The UK’s competition watchdog has imposed fines of more than £100m on the pharmaceutical company Advanz and its former private equity owners after it was found to have inflated the price of its thyroid tablets by up to 6,000%. An …

Pharma firm Advanz fined after thyroid drug price hike of 6,000% Read More »

Is medical cannabis really a magic bullet?

Research increasingly suggests that extracts from the plant are effective in treating pain, anxiety, epilepsy and more, but experts still preach caution around recreational use In 2017, Mikael Sodergren, a liver and pancreatic cancer surgeon at Imperial College healthcare NHS trust, was finding himself becoming increasingly interested in the potential role of medical cannabis in …

Is medical cannabis really a magic bullet? Read More »

Morrison government silent on contact with Pfizer global chief after Kevin Rudd intervenes in vaccine talks

Under fire for his government not reaching out to the pharmaceutical giant’s international head, health minister Greg Hunt also avoided naming the former Labor PM Scott Morrison and federal health minister Greg Hunt have not denied claims that they failed to press Australia’s case for more vaccine doses directly with Pfizer’s global chief, after revelations …

Morrison government silent on contact with Pfizer global chief after Kevin Rudd intervenes in vaccine talks Read More »

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams

On morning TV this week, two of the developers of the Oxford vaccine were faced with an outpouring of thanks. It was very much deserved – and very hard for them to reply I don’t watch much TV in the morning – I put it roughly on a par with smoking weed in the morning …

How should you respond to deep, sincere praise? There are no easy answers | Zoe Williams Read More »

I thought HIV meant death but it led me to fight to save millions of lives | Vuyiseka Dubula

Twenty years ago in South Africa people were dying unable to access expensive antiretrovirals. The creation of the Global Fund was gamechanging In 2001, at the age of 22 – when I thought my life had just begun – I was diagnosed with HIV. At that time, the diagnosis felt like a death sentence. Every …

I thought HIV meant death but it led me to fight to save millions of lives | Vuyiseka Dubula Read More »

Centre Court ovations, limbo-dancing grans – it’s all been humbling, say Oxford vaccine creators

Sarah Gilbert and Catherine Green tell of their pioneering vaccine work but warn the battle is far from over Coronavirus – latest updates See all our coronavirus coverage Sarah Gilbert’s experiences at Wimbledon last week clearly had a profound impact on the medical researcher – though it was not the standing ovation that the vaccine …

Centre Court ovations, limbo-dancing grans – it’s all been humbling, say Oxford vaccine creators Read More »

Million Pfizer jabs face being dumped after Israel-UK swap deal fails

Israel says technical issues have scuppered deal to give UK Covid vaccines expiring on 30 July Coronavirus – latest updates See all our coronavirus coverage More than a million Pfizer/BioNTech vaccine doses held in Israel that are due to expire at the end of July may be thrown away after attempts to broker a swap …

Million Pfizer jabs face being dumped after Israel-UK swap deal fails Read More »

The Oxford vaccine: the trials and tribulations of a world-saving jab

Amid bemusement from scientists at the deluge of often undeserved criticism, the Guardian pieces together the story behind the vaccine’s successes and failures Coronavirus – latest updates See all our coronavirus coverage In January 2020, when most of the world slept soundly in ignorance of the pandemic coming its way, a group of scientists at …

The Oxford vaccine: the trials and tribulations of a world-saving jab Read More »

Drug firms giving MPs ‘hidden’ funding, research shows

Pharmaceutical industry has “hidden web of policy influence” over dozens of all-party parliamentary groups Drug companies are giving groups of MPs and peers that campaign on health issues hundreds of thousands of pounds a year in “hidden” funding that could hand them “undue influence”, research has found. The pharmaceutical industry has built up a “hidden …

Drug firms giving MPs ‘hidden’ funding, research shows Read More »

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy

Casual vaccine chat is today’s only form of small talk, so it’s not surprising it would take a lightheartedly tribal turn. Ultimately, of course, gratitude is at the heart of the conversation Last week, I had cause to go searching for images of men getting vaccinated (it’s not a fetish – it was for work) …

Moderna, Pfizer or AstraZeneca? The ridiculous, diverting rise of vaccine envy Read More »

Covid jabs for billions of humans will earn their makers billions of dollars

We look at the drug firms – led by Pfizer and Moderna – that are set to profit most in an unprecedented global vaccination drive Coronavirus – latest updates See all our coronavirus coverage Drugmakers led by US firms Pfizer and Moderna stand to make tens of billions of dollars from their Covid-19 vaccines this …

Covid jabs for billions of humans will earn their makers billions of dollars Read More »

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now?

Having built a big operation during the pandemic it could stick or twist but either way investors will soon want a decision What’s AstraZeneca’s strategy in Covid treatments? In the short term, there is no confusion: the company will continue pumping out vaccine doses, will keep signing partnerships and will try to ignore churlishness in …

Vaccines were not part of AstraZeneca’s grand strategy, so what’s the plan now? Read More »

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told

G7 summit hears move would slash the cost of jabs and accelerate the rollout of programmes across the developing world Britain and Germany were last night under intense pressure to drop their resistance to proposals that would slash the cost of Covid-19 vaccines, following accusations that an agreement at the G7 summit to fund a …

Drop Covid vaccine patent rules to save lives in world’s poorest countries, Britain and Germany told Read More »

More research funding needed to avoid drug-resistant pandemic, warns report

Smaller firms are developing most antibiotics targeting superbugs but often at risk of bankruptcy Small drugmakers and biotech firms that are developing the bulk of new antibiotics need far more financial support, according to a new report, which warned that without these life-saving medicines there could be a pandemic of drug-resistant infections, worse than Covid-19. …

More research funding needed to avoid drug-resistant pandemic, warns report Read More »

Thailand starts Covid vaccine drive using jabs made by king’s firm

Country aims to vaccinate 70% of people this year but experts express doubts amid supply concerns Coronavirus – latest updates See all our coronavirus coverage Thailand has started its Covid vaccination campaign amid concerns over the supply of doses, which are mainly being produced locally by a royal-owned company that has no prior experience of …

Thailand starts Covid vaccine drive using jabs made by king’s firm Read More »

Helen Murray Free obituary

Chemist who transformed medical screening by developing glucose dipsticks In the 1950s the US chemist Helen Murray Free, who has died aged 98, was responsible for developing glucose dipsticks. Their use led to much simpler medical screening methods that are still widely used today for pregnancy tests, the diagnosis and monitoring of diabetes, and to …

Helen Murray Free obituary Read More »

Fears of side-effects fuel reluctance to get Covid jabs, survey finds

Imperial College London survey in 15 countries also reveals worries that vaccines had not been tested enough Coronavirus – latest updates See all our coronavirus coverage Most people who are reluctant to be vaccinated against Covid are worried about side-effects and whether the vaccines have been adequately tested, a survey in 15 countries has shown. …

Fears of side-effects fuel reluctance to get Covid jabs, survey finds Read More »

SCAN Health’s new program to tackle senior isolation focuses on connections with peers

To tackle loneliness among seniors — which can have serious repercussions on health — Medicare Advantage plan provider SCAN Health has launched a togetherness program. The program is founded on senior-to-senior interactions, both virtual and, eventually, in-person.

Stoush over cost of hormone patches puts Australian women’s health at risk

Sandoz Australia is threatening to withdraw patches from public subsidy list if government does not agree to price hike Pharmaceutical company Sandoz Australia is in a standoff with the federal government over the pricing of hormone patches relied on by thousands of women. There is a risk that if an agreement is not reached the …

Stoush over cost of hormone patches puts Australian women’s health at risk Read More »

MPs tell Johnson: you have a duty to help vaccinate the world

Exclusive: group urges prime minister to tackle ‘desperate shortage’ in developing nations Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has a “moral duty” to immediately start matching each vaccine administered at home with a donated dose to poorer countries across the world, a cross-party group of MPs and peers has said. …

MPs tell Johnson: you have a duty to help vaccinate the world Read More »

Taiwan accuses China of interfering with Covid vaccine deals

President says agreement with German firm BioNTech has been delayed after Beijing intervention Coronavirus – latest updates See all our coronavirus coverage Taiwan’s president has accused China of interfering in its vaccine acquisition programme, as the island continues to battle hundreds of daily new cases of Covid-19 with low supplies of vaccines. Taiwan has received …

Taiwan accuses China of interfering with Covid vaccine deals Read More »

UK pharmaceutical firm Ventura agrees to £958m takeover deal

Private equity firm Carlyle Group to buy company that is developing inhaled treatment for Covid-19 Coronavirus – latest updates See all our coronavirus coverage The British pharmaceutical company Vectura Group, which is developing a pioneering inhaled treatment for Covid-19, has agreed a £958m takeover by Carlyle Group as it looks set to become the latest …

UK pharmaceutical firm Ventura agrees to £958m takeover deal Read More »

Moderna jab stops Covid transmission in people aged 12 to 18, trial finds

Moderna becomes second manufacturer to announce successful trial results in younger people Coronavirus – latest updates See all our coronavirus coverage Mass vaccination of children against Covid-19 moved a step closer as Moderna became the second manufacturer to announce successful trial results, showing its vaccine can stop transmission in people aged 12 to 18. Pfizer/BioNTech’s …

Moderna jab stops Covid transmission in people aged 12 to 18, trial finds Read More »

Labour says UK must ‘get off the fence’ over global Covid vaccine access

Shadow trade secretary backs US call for patent waiver as party proposes plan to increase production in poorer countries Coronavirus – latest updates See all our coronavirus coverage The Labour party is urging Boris Johnson to lead a drive by rich countries to boost global Covid-19 vaccine production and is warning the threat from new …

Labour says UK must ‘get off the fence’ over global Covid vaccine access Read More »

Poorer countries face long delays in receiving Covid vaccines

Efforts in Africa and elsewhere hit by decision not to export AstraZeneca jab from India until end of year Coronavirus – latest updates See all our coronavirus coverage Vaccine programmes across Africa and much of the developing world will suffer big delays after the world’s biggest producer said it would not be exporting the Oxford/AstraZeneca …

Poorer countries face long delays in receiving Covid vaccines Read More »

Delay in giving second jabs of Pfizer vaccine improves immunity

Study finds antibodies against Sars-CoV-2 three-and-a-half times higher in people vaccinated again after 12 weeks rather than three Coronavirus – latest updates See all our coronavirus coverage The UK’s decision to delay second doses of coronavirus vaccines has received fresh support from research on the over-80s which found that giving the Pfizer/BioNTech booster after 12 …

Delay in giving second jabs of Pfizer vaccine improves immunity Read More »

Moderna says it has signed deal with Australia to supply 25m doses of Covid vaccine

Company says 10m could arrive by year’s end as it eyes local manufacturing opportunities Australians will have another vaccine option after the pharmaceutical company Moderna announced it has signed a deal with the federal government to provide 25m doses of its mRNA-based vaccine to the nation. The announcement was made overnight in a press release …

Moderna says it has signed deal with Australia to supply 25m doses of Covid vaccine Read More »

Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety

The pharmaceutical giant argues waiving intellectual property protections could see scarce inputs snapped up making it harder to produce vaccines Full Story podcast: Is Australia stopping the world’s poorest nations from accessing cheap vaccines? What is patent waiving and will it solve the global shortage? Pfizer has warned Australia against joining a growing push to …

Pfizer warns Australia a Covid vaccine patent waiver could harm supply and safety Read More »

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote

Investors are lining up to oppose pay-and-perks plan for Pascal Soriot worth up to £17.8m for 2021 AstraZeneca could be forced to rip up plans to boost the pay of its chief executive, Pascal Soriot, as investors prepare to vote on proposals that could take his remuneration after nearly a decade at the helm of …

AstraZeneca chief executive’s pay rise in doubt ahead of investor vote Read More »

India records almost 4,200 Covid deaths in a day

County reports more than 400,000 new infections but experts suspect figures are gross underestimate Coronavirus – latest updates See all our coronavirus coverage Covid-19 deaths surged past 4,000 for the first time in India on Saturday in one of the world’s worst outbreaks. India reported a national record of 4,187 new deaths on Saturday. Continue …

India records almost 4,200 Covid deaths in a day Read More »

The Guardian view on waiving Covid vaccine patents: protect the world, not big pharma | Editorial

The US is now backing plans that could help billions more access vaccines. The UK should follow suit The rapid emergence of Covid vaccines has been a remarkable yet bittersweet success, pointing to both humanity’s scientific achievements and its social and economic failures. Experts created them at extraordinary speed; yet as the pandemic rages, many …

The Guardian view on waiving Covid vaccine patents: protect the world, not big pharma | Editorial Read More »

US support for Covid vaccine patent waivers puts pressure on EU and UK

Analysis: Joe Biden’s support for idea is vital but it won’t happen without backing of other rich nations Coronavirus – latest updates See all our coronavirus coverage It was a “seismic decision” by Joe Biden, the US president, say campaigners who have fought for the demolition of patent protection on vaccines and drugs for decades. …

US support for Covid vaccine patent waivers puts pressure on EU and UK Read More »

EU ‘ready to discuss’ waiver on Covid vaccine patents

Emmanuel Macron also supports US-backed proposal described as a gamechanger by WHO Coronavirus – latest updates See all our coronavirus coverage The head of the European commission, Ursula von der Leyen, has said the bloc is “ready to discuss” a US-backed proposal for a waiver on the patents for Covid-19 vaccines and the French president, …

EU ‘ready to discuss’ waiver on Covid vaccine patents Read More »

India wants access to cheap copies of Covid vaccines. So why is Australia holding out?

More than 100 countries are pushing for a temporary waiver of IP rules to boost vaccine access for developing nations. Why hasn’t it been approved? As India grapples with a devastating Covid wave that has overwhelmed its hospitals, offers of aid, including from Australia, have flooded in from around the world. The help on offer …

India wants access to cheap copies of Covid vaccines. So why is Australia holding out? Read More »

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs

Health secretary says greater supplies of vaccine will help safeguard progress in tackling coronavirus Coronavirus – latest updates See all our coronavirus coverage The UK has ordered a further 60m doses of the Pfizer/BioNTech Covid vaccine in an effort to ensure that booster jabs can be given from this autumn, the government has announced. The …

UK orders 60m more doses of Pfizer Covid vaccine for booster jabs Read More »

What Covid vaccines does the UK have and which are in the works?

As Valneva recruits volunteers for final stage trials of its vaccine, here is the current state of play in Britain Coronavirus – latest updates See all our coronavirus coverage Vaccines to protect against the coronavirus were designed, tested and manufactured in record time, and several have been approved for use in the UK vaccination programme, …

What Covid vaccines does the UK have and which are in the works? Read More »

In the fight against Covid, have we been inoculated against compassion? | Letters

Dr Mohga Kamal-Yanni says world leaders must stop putting big pharma’s profits before people’s lives. Sue Hoar wonders why more is not being done to help Covid patients in India The shortfall in Covid vaccine doses going to the Covax vaccine-sharing scheme is deeply worrying, and highlights a massive flaw in the plans to provide …

In the fight against Covid, have we been inoculated against compassion? | Letters Read More »

GlaxoSmithKline faces dose of strong medicine from US investor

This week’s lacklustre results will strengthen boss Emma Walmsley’s case for reform – but also inspire her critics When the American hedge fund Elliott Management took a sizeable stake in GlaxoSmithKline this month, the drugmaker’s shares jumped 5% on speculation of a possible shake-up at the company. GSK’s chief executive, Emma Walmsley, will face questions …

GlaxoSmithKline faces dose of strong medicine from US investor Read More »

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi

Pharmaceutical companies insist secrecy is the only way. But what if they were obliged to share recipes and supply chains? Biolyse is a small pharmaceutical manufacturer in Canada with a simple proposition: provide a recipe for a coronavirus vaccine, and it will produce 20m doses for nations in the global south. It has approached AstraZeneca …

The world is desperate for more Covid vaccines – patents shouldn’t get in the way | Stephen Buranyi Read More »

EU asks states to back legal action against AstraZeneca

Commission move causes concern about bringing case against key supplier of Covid vaccines Coronavirus – latest updates See all our coronavirus coverage EU capitals have been asked by the European commission to back legal action against AstraZeneca by the end of the week over an alleged breach of its contractual obligations to supply member states …

EU asks states to back legal action against AstraZeneca Read More »

Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’

Pfizer boss flags likelihood that extra jabs will be required – raising prospect of increased global demand Covid booster shot could be needed after nine to 12 months, White House says Experts say suggestions that a third dose of Pfizer may be needed within 12 months again show why Australia “urgently” needs to develop an …

Covid booster shot warning ‘underlines urgent need for Australia to make mRNA vaccines’ Read More »

UK strategy of backing several Covid vaccines seems to be paying off

Analysis: buying new and existing technologies ensured alternatives if a vaccine failed or had supply issues Coronavirus – latest updates See all our coronavirus coverage The government has said the decision by Johnson & Johnson to delay the supply of its Covid vaccine to Europe, while the US investigates reports of six cases of unusual …

UK strategy of backing several Covid vaccines seems to be paying off Read More »

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay

Company has said it is postponing deployment in Europe following concerns about blood clots in US Coronavirus – latest updates See all our coronavirus coverage The European commission is seeking “urgent clarification” from Johnson & Johnson after the company’s “completely unexpected” announcement that it has decided to delay the deployment of its coronavirus vaccine across …

EU seeking ‘urgent clarification’ on Johnson & Johnson Covid vaccine delay Read More »

African health workers left without Covid jabs as paltry supplies dwindle

Fear of third wave and new variants as sub-Saharan vaccine distribution is dogged by supply disruption Coronavirus – latest updates See all our coronavirus coverage Millions of healthcare workers in sub-Saharan Africa continue to risk their lives to fight Covid-19 as authorities across the continent struggle to obtain and distribute vaccines to frontline medical staff. …

African health workers left without Covid jabs as paltry supplies dwindle Read More »

Australia reports second blood clot case ‘likely’ linked to AstraZeneca Covid vaccine

Woman in her 40s in Western Australia reported to be in hospital in a stable condition after developing clot Health authorities have concluded a second case of a rare blood clot syndrome in Australia “is likely” linked to the AstraZeneca vaccine. The case occurred in a woman in her 40s who received the AstraZeneca Covid-19 …

Australia reports second blood clot case ‘likely’ linked to AstraZeneca Covid vaccine Read More »

Global Covid vaccine rollout threatened by shortage of vital components

Pharmaceutical firms warn of delays to items such as the large bags in which vaccine cells are grown Coronavirus – latest updates See all our coronavirus coverage Vaccine-makers around the world face shortages of vital components including large plastic growbags, according to the head of the firm that is manufacturing a quarter of the UK’s …

Global Covid vaccine rollout threatened by shortage of vital components Read More »

EU agency examines reports of blood clots with J&J Covid vaccine

EMA says four serious cases reported, one fatal, and also expands inquiry into AstraZeneca vaccine Coronavirus – latest updates See all our coronavirus coverage The EU’s drug regulator is reviewing reports of rare blood clots in four people who received Johnson & Johnson’s Covid-19 vaccine and has expanded its inquiry into AstraZeneca’s shot to include …

EU agency examines reports of blood clots with J&J Covid vaccine Read More »

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk?

Experts say the development of blood clots after getting the jab is still an ‘exceedingly rare’ side effect. So what triggered the government’s change in position? Australia’s vaccine rollout is facing a major shake-up after the federal government heeded the advice of its independent health expert advisory body to avoid giving the AstraZeneca vaccine to …

What does Australia’s new advice on the AstraZeneca Covid vaccine mean and what is the risk? Read More »

Coronavirus: UK expert urges people in 20s to keep getting vaccine

Prof David Spiegelhalter says advantages of vaccinating young people far outweigh risks Coronavirus – latest updates See all our coronavirus coverage People in their 20s should continue to get vaccinated against Covid despite the very rare cases of blood clotting linked to the Oxford/AstraZeneca vaccine because of the wider benefit to their families, friends and …

Coronavirus: UK expert urges people in 20s to keep getting vaccine Read More »

UK ministers silent on AstraZeneca vaccine shipment to Australia

Downing Street will not confirm or deny report that more than 700,000 Covid jabs were sent after EU blocked export Coronavirus – latest updates See all our coronavirus coverage British ministers and officials did not deny that more than 700,000 shots of the AstraZeneca vaccine were secretly dispatched from the UK to Australia a few …

UK ministers silent on AstraZeneca vaccine shipment to Australia Read More »

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam

England’s deputy chief medical officer says delay would be precaution against rare side-effect of blood clots Coronavirus – latest UK updates See all our coronavirus coverage People under 30 have been told there may be a “small delay” to when they will receive a coronavirus vaccine, given adults in that age group are now being …

Under-30s may have ‘small delay’ in getting Covid jab, says Jonathan Van-Tam Read More »

AstraZeneca jab: UK government says concerns being investigated thoroughly

People urged to keep getting Covid vaccine, with EMA and MHRA expected to give updates on investigation into rare blood clots Coronavirus – latest updates See all our coronavirus coverage Government advisers say concerns over the Oxford/AstraZeneca jab are being taken “very seriously” and “very thoroughly” investigated, before an imminent announcement by the vaccines regulator. …

AstraZeneca jab: UK government says concerns being investigated thoroughly Read More »

AstraZeneca Covid vaccine: weighing up the risks and rewards

Despite scientific advice to continue getting the jab, answers about fatal blood clots are urgently needed Coronavirus – latest updates See all our coronavirus coverage Vaccines have side-effects, as do all medicines. Most often, jabs cause sore arms, a headache or a bit of nausea – none of which would be very significant when weighed …

AstraZeneca Covid vaccine: weighing up the risks and rewards Read More »

Medicines watchdog says no decision made AstraZeneca jab for under-30s

Medicines Healthcare products Regulatory Authority was considering restricting vaccine amid concerns over rare blood clots Coronavirus – latest updates See all our coronavirus coverage The UK’s medicines regulatory body has said that no decision has been made on any regulatory action relating to the Oxford/AstraZeneca vaccine following reports it is considering restricting use of the …

Medicines watchdog says no decision made AstraZeneca jab for under-30s Read More »

Blood clot cases ‘could dent faith of young women in AstraZeneca’

Experts urge public to go for inoculations as benefits far outweigh potential complications Coronavirus – latest updates See all our coronavirus coverage Health officials are becoming increasingly worried that younger people will reject Covid jabs as concerns about the AstraZeneca vaccine continue to grow. A total of 30 cases of rare blood clots have been …

Blood clot cases ‘could dent faith of young women in AstraZeneca’ Read More »

Two new vaccines on the way – with more to follow this year

Half of UK adults have had a first jab, and future supplies of millions of doses look assured Coronavirus – latest updates See all our coronavirus coverage Two very different jabs have been responsible for inoculating Britain’s strikingly high number of vaccine recipients – with more than half of the country’s adult population having now …

Two new vaccines on the way – with more to follow this year Read More »

Pfizer vaccine has 91% efficacy for up to six months, trial shows

Findings based on two doses three weeks apart are first to show shot remains effective for many months Coronavirus – latest updates See all our coronavirus coverage The coronavirus vaccine developed by Pfizer and its German partner BioNTech protects against symptomatic Covid for up to six months, an updated analysis of clinical trial data has …

Pfizer vaccine has 91% efficacy for up to six months, trial shows Read More »

UK to make up to 60m doses of Novavax Covid vaccine under GSK deal

Deal is intended to boost domestic supply amid fears potential export bans could hit vaccine shipments Coronavirus – latest updates See all our coronavirus coverage The UK will produce up to 60m doses of a Covid-19 vaccine under a new deal struck to boost domestic supply, amid fears over potential export bans hitting shipments of …

UK to make up to 60m doses of Novavax Covid vaccine under GSK deal Read More »

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn

The company has struggled, like its rivals, to keep up with demand. But it has achieved great things at low prices AstraZeneca is one of the shining stars of the pandemic. Not only did it produce a vaccine where other big players failed, the UK-Swedish company has pledged to sell it at cost until it …

Safe, stable, sold at cost: AstraZeneca’s vaccine deserves celebration, not scorn Read More »

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK

Serum Institute boss Adar Poonawalla has rented a Mayfair mansion for £50,000 a week Coronavirus – latest updates See all our coronavirus coverage The AstraZeneca vaccine has made Prof Sarah Gilbert – who led the Oxford team that created it – one of the UK’s most famous modern scientists and turned the Anglo-Swedish pharmaceutical company …

‘Vaccine prince’: the Indian billionaire set to make Covid jabs for the UK Read More »

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data

Worldwide focus on Covid-19 means a ‘minor issue’ is getting media attention, experts say Australia’s Covid vaccine rollout would be ‘dire’ without local AstraZeneca production, health chief says Australia’s drug regulator, the Therapeutic Goods Administration, has dismissed questions raised about “outdated information” in AstraZeneca vaccine data by the US Data and Safety Monitoring Board. On …

AstraZeneca vaccine: Australia’s drug regulator dismisses questions raised in US about outdated data Read More »

EU to widen criteria for possible Covid vaccine export bans

Bloc expected to assess countries’ Covid vaccination coverage and record in facilitating exports to EU Coronavirus – latest updates See all our coronavirus coverage The EU is expected to take into account the level of vaccination coverage in a country and its record in facilitating exports to the bloc when deciding on whether to prohibit …

EU to widen criteria for possible Covid vaccine export bans Read More »

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial

Vaccinating the world is the only way out of Covid, but a mixture of nationalism and protectionism is blocking the exit Covid-19 has proved to be the greatest humanitarian and economic disaster of the century. A reported 2.7 million people have already died from the pathogen. Its recession is estimated to be twice as deep …

The Guardian view on pandemic politics: we need cooperation, not confrontation | Editorial Read More »

Boris Johnson: vaccine cooperation vital to help combat third Covid wave

PM stresses need to work with EU and says surge in infections is likely to ‘wash up on our shores’ Coronavirus – latest updates See all our coronavirus coverage Boris Johnson has urged international cooperation over vaccines, saying a third wave of coronavirus elsewhere in Europe would inevitably affect the UK. The prime minister’s remarks …

Boris Johnson: vaccine cooperation vital to help combat third Covid wave Read More »

Vaccine wars: the week that rocked the UK’s Covid jab rollout

After a week of bans, U-turns and warnings of supply shortfalls, public confidence in vaccination has been dented. Can Britain get back on the fast track out of lockdown? Coronavirus – latest updates See all our coronavirus coverage For Stacey Harris, the hardest part of organising vaccinations over the last couple of months has been …

Vaccine wars: the week that rocked the UK’s Covid jab rollout Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously

Three Scandinavian countries reserve judgment one day after EMA says shot is safe and effective Coronavirus – latest updates See all our coronavirus coverage France has said only people aged 55 and over should receive the AstraZeneca Covid-19 vaccine, and three Scandinavian countries have reserved judgment until next week, a day after Europe’s health regulator …

France limits AstraZeneca Covid jab to over-55s as Europe treads cautiously Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe

Pooling the European Covid vaccine effort was a noble idea. In practice, it has been a disaster In the race between vaccines and new Covid-19 variants, I am on the losing team. There is a simple reason for this, and it is because I live in the European Union – in my case, in Spain. …

The EU’s AstraZeneca vaccine stance will cost lives, here in Spain and all over Europe Read More »

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

Patrick Vallance: the adviser who spoke scientific truth to power

The UK’s chief scientific adviser loves good food, enjoys a Scandi drama – and has been called ‘the richest civil servant in history’ Sir Patrick Vallance spent his 60th birthday at a podium in Downing Street, flanking Boris Johnson. Whatever plans he had were scrapped. Continue reading…

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

How are Covid vaccines produced and why have there been delays?

The newness of some of the technology and gaps in global preparedness have led to bottlenecks Coronavirus – latest updates See all our coronavirus coverage When the first Covid-19 vaccines were approved in the UK and elsewhere three months ago, many thought the end of the pandemic was almost within reach. Few, however, had anticipated …

How are Covid vaccines produced and why have there been delays? Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

European countries to resume AstraZeneca jabs after safety backing

EMA says benefits outweigh risks but it is continuing to study possible link with very rare blood clotting disorder Coronavirus – latest updates See all our coronavirus coverage Italy, France, Germany and several other countries will resume administering AstraZeneca jabs from Friday after Europe’s medicines regulator said the vaccine was “safe and effective” and its …

European countries to resume AstraZeneca jabs after safety backing Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

EU to send formal letter to AstraZeneca in Covid vaccine dispute

Bloc hopes to resolve row as it emerges big member states back threat to halt jab exports Coronavirus – latest updates See all our coronavirus coverage The EU is to send a formal letter to AstraZeneca in an attempt to resolve its dispute over vaccine supplies, a spokesperson has said, as it emerged that capitals …

EU to send formal letter to AstraZeneca in Covid vaccine dispute Read More »

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA

European agency seeks to allay blood clot fears as Germany, France and Italy temporarily suspend use Coronavirus – latest updates See all our coronavirus coverage Europe’s medicines regulator has moved to stifle spiralling concern about the Oxford/AstraZeneca vaccine, saying the shot’s benefits outweigh the risks after four major EU countries announced they were suspending its …

Benefits of Oxford/AstraZeneca vaccine outweigh any risk, says EMA Read More »

What price a child’s life? India’s quest to make rare disease drugs affordable

Parents whose only hope was finding foreign sponsorship or a clinical trial are now looking for homegrown breakthroughs For three years, Vidya tried to find the cause of her son’s recurrent fevers and low cognitive development. When she found out, she was devastated. Vineeth, 10, has an incurable illness – mucopolysaccharidosis type 2 – that …

What price a child’s life? India’s quest to make rare disease drugs affordable Read More »

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns

Deployment of Oxford vaccine temporarily deferred after latest reports from Norway Coronavirus – latest updates See all our coronavirus coverage Ireland is suspending use of the Oxford/AstraZeneca vaccine against Covid as a precautionary measure following further reports of blood clots in people who have received it, this time from Norway. The deputy chief medical officer, …

Ireland suspends AstraZeneca Covid vaccine over blood clot concerns Read More »

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports

Health agency suspends use of Covid jab but says no conclusive link has been established Coronavirus – latest updates See all our coronavirus coverage Denmark’s national health agency has said it is temporarily suspending inoculations with the AstraZeneca vaccine after blood clots formed in several people who had the jab, one of whom has reportedly …

Denmark pauses use of AstraZeneca vaccine to investigate blood clot reports Read More »

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot

The scientific community are rising to the challenge, undertaking an unprecedented global health programme Pascal Soriot is the chief executive officer of AstraZeneca Coronavirus – latest updates See all our coronavirus coverage Covid-19 is a virus that knows no boundaries and has inflicted terrible suffering across the world. Now more than ever, we must remember …

At AstraZeneca, we know that until everyone is safe from Covid, no one is safe | Pascal Soriot Read More »

BioNTech co-founder says gender equality made vaccine possible

Özlem Türeci credits firm’s more than 50% female workforce for speed at which first viable jab created The co-founder and chief medical officer of BioNTech has credited its speed at producing a viable vaccine to the fact its workforce is more than 50% female. Speaking on International Women’s Day, Özlem Türeci also said the fact …

BioNTech co-founder says gender equality made vaccine possible Read More »

NHS to use world’s most expensive drug to treat spinal muscular atrophy

Zolgensma, which costs £1.79m for one-off treatment, will be available in England this year for the first time The world’s most expensive drug, which treats babies and young children with a rare and often fatal degenerative disorder, will be available this year for the first time on the NHS in England. Zolgensma, which costs £1.79m …

NHS to use world’s most expensive drug to treat spinal muscular atrophy Read More »

From Pfizer to Moderna: who’s making billions from Covid vaccines?

The companies in line for the biggest gains – and the shareholders who have already made fortunes Coronavirus – latest updates See all our coronavirus coverage The arrival of Covid-19 vaccines promises a return to more normal life – and has created a global market worth tens of billions of dollars in annual sales for …

From Pfizer to Moderna: who’s making billions from Covid vaccines? Read More »

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia

Row continues between EU and drug firm after shortfall in vaccine deliveries to bloc Coronavirus – latest updates See all our coronavirus coverage Italy has blocked the export of 250,000 doses of the Oxford/AstraZeneca vaccine to Australia in an escalation of a row with the Anglo-Swedish company. In the first such intervention under the EU’s …

Italy blocks export of 250,000 AstraZeneca vaccine doses to Australia Read More »

Thalidomide scandal: Sunak pledges lifetime support for survivors

Joy and relief from campaigners as chancellor’s budget extends support that had been due to run out in 2023 Analysis: Sunak digs in for battle against financial cost of Covid Budget 2021: key points at a glance Budget 2021 live: Sunak to freeze income tax thresholds Thalidomide campaigners have reacted with relief and joy after …

Thalidomide scandal: Sunak pledges lifetime support for survivors Read More »

Pfizer vaccine may be less effective in people with obesity, says study

Healthcare workers with obesity found to produce only about half the antibodies healthy people do Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine may be less effective in people with obesity, data suggests. Italian researchers have discovered that healthcare workers with obesity produced only about half the amount of antibodies in …

Pfizer vaccine may be less effective in people with obesity, says study Read More »

Life-extending drug for incurable breast cancer approved for NHS use

About 3,300 women a year may benefit from decision to approve ribociclib Women with incurable advanced breast cancer will be able to get a drug from the NHS that can potentially extend their life by almost eight months, under new guidance. The National Institute for Health and Care Excellence (Nice) has approved the drug – …

Life-extending drug for incurable breast cancer approved for NHS use Read More »

Blair says collaboration on Covid could have cut three months off crisis

Former prime minister tells the Guardian the world must be better prepared for the next pandemic World leaders could have cut the length of the Covid outbreak by three months if they had collaborated on vaccines, testing and drugs, Tony Blair has claimed as he launched a report on preparing for the next deadly pandemic. …

Blair says collaboration on Covid could have cut three months off crisis Read More »

How UCSF created a data platform that leverages 150+ social determinants variables

UCSF’s interactive data platform allows users to drill down into 150 social determinants of health variables. This data, layered with EHR data, can give researchers and clinicians invaluable insights into the nexus of social factors and health.

Vaccine clinical trials for Covid variants to start in summer, MPs told

Updated versions of vaccine are being developed in case variants evade immunity provided by current shots Coronavirus – latest updates See all our coronavirus coverage Clinical trials of vaccines against new variants of coronavirus will start in the summer to ensure updated boosters are available for the autumn if needed, Oxford’s lead vaccine researcher has …

Vaccine clinical trials for Covid variants to start in summer, MPs told Read More »

Number of UK Covid vaccinations falls by a third as vaccine supply dips

Factors at play include high uptake plus stockpiling for second doses, but Matt Hancock promises ‘bumper weeks in March’ Coronavirus – latest updates See all our coronavirus coverage The number of Covid vaccines administered in the UK has fallen by over a third in the last week as ministers warned of a short-term dip in …

Number of UK Covid vaccinations falls by a third as vaccine supply dips Read More »

South Africa leads backlash against big pharma over access to Covid vaccines

Pressure mounts for patent waivers to allow poorer countries to develop their own manufacturing capacity to boost availability The domination of global medicine by major pharmaceutical companies needs to be confronted to provide fairer access to vaccines, a leading South African official has said. The scramble over Covid vaccines should alert rich countries to the …

South Africa leads backlash against big pharma over access to Covid vaccines Read More »

‘It shows what we’re capable of’: the NHS’s vaccine triumph

A huge effort has helped the UK provide 14m first doses of Covid vaccines in about two months Coronavirus – latest updates See all our coronavirus coverage In St Albans, GPs took over a former nightclub to provide Covid vaccinations every 20 seconds; in Carnforth, Lancashire, delivering jabs was helped by volunteers from the local …

‘It shows what we’re capable of’: the NHS’s vaccine triumph Read More »

AstraZeneca says vaccine against new Covid variants may take six months

Anglo-Swedish pharmaceutical firm’s profits rise to $7.4bn as main business ‘remains strong’ Coronavirus – latest updates See all our coronavirus coverage AstraZeneca has said it could take between six and nine months to produce Covid-19 vaccines that are effective against new variants of the coronavirus. The company’s vaccine, developed jointly with scientists at the University …

AstraZeneca says vaccine against new Covid variants may take six months Read More »

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence

From doubts about safety in older people to questions about variants, scientists have faced a battle to convince the public and regulators Coronavirus – latest updates See all our coronavirus coverage The Oxford University/AstraZeneca vaccine against Covid has barely been out of the news from the moment the race to protect the world’s population from …

A series of knocks: Oxford/AstraZeneca’s bumpy road to Covid vaccine confidence Read More »

Oxford Covid vaccine 10% effective against South African variant, study suggests

Small-scale trial of vaccine’s efficacy shows it offers very little protection against mild to moderate infection Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine offers as little as 10% protection against the Covid variant first seen in South Africa, researchers have suggested. Scientists who conducted a small-scale trial of the vaccine’s …

Oxford Covid vaccine 10% effective against South African variant, study suggests Read More »

CBD will go on sale in Australia, but first manufacturers will have to prove it works

While CBD has been approved for over-the-counter sale, there are regulatory hurdles to clear before it actually appears in pharmacies “You can have as much whiskey as you like, but there’s no whiskey available,” says Prof Iain McGregor, psychopharmacologist and academic director of the Lambert Initiative for Cannabinoid Therapeutics, when asked to describe the rules …

CBD will go on sale in Australia, but first manufacturers will have to prove it works Read More »

Oxford Covid vaccine just as effective against Kent variant, trials suggest

Scientists behind AstraZeneca vaccine say it has similar efficacy against variant as against original Covid Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca coronavirus vaccine is just as effective at fighting the UK variant as it is the original virus, new research suggests. Oxford University researchers who developed the vaccine say it …

Oxford Covid vaccine just as effective against Kent variant, trials suggest Read More »

UK orders 50m doses of Covid vaccines in fight against variants

Government to work with German firm CureVac on tackling potential mutations Coronavirus – latest updates See all our coronavirus coverage The UK government has signed a deal for at least 50m doses of vaccines that could combat new variants of coronavirus, and is to work with the German manufacturer to help develop them. The Department …

UK orders 50m doses of Covid vaccines in fight against variants Read More »

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine

Companies hope to have next generation of vaccines against emerging variants by next year GlaxoSmithKline and Germany’s CureVac have reached a €150m (£132m) agreement to develop a next generation of Covid-19 vaccines targeting new emerging variants in the pandemic. The two companies said they they plan to work jointly to develop a vaccine that can …

GSK and CureVac sign £132m deal to develop multi-variant Covid vaccine Read More »

Single dose of AstraZeneca vaccine could cut transmission by 67%

One jab could also offer protection of up to 76% for up to 12 weeks, a new study shows Coronavirus – latest updates See all our coronavirus coverage A single dose of the Oxford/AstraZeneca vaccine may reduce transmission by 67% and give protection of 76% for up to 12 weeks, a study shows. Vaccine efficacy …

Single dose of AstraZeneca vaccine could cut transmission by 67% Read More »

Even with vaccines, we still need treatments for Covid. So what works?

Analysis: death rates in intensive care are falling as doctors identify more ways to help those with the disease Coronavirus – latest updates See all our coronavirus coverage Vaccines may have been described as the great escape route from the Covid pandemic – but treatments, which are bringing down death rates, will be needed as …

Even with vaccines, we still need treatments for Covid. So what works? Read More »

Celltrion Receives Health Canada’s Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis

Shots: The Health Canada has granted a NOC which is based on clinical evidence for Remsima/CT-P13 SC vs CT-P13 IV up to 1year in patients with RA. The results demonstrated that switching patients from Remsima IV to its SC formulation @30wks. is comparable to maintaining Remsima SC up to 54wks. The therapy has shown similar …

Celltrion Receives Health Canada’s Approval for Remsima SC (biosimilar, infliximab) for Rheumatoid Arthritis Read More »

EU to publish revised rules after Covid vaccine border fiasco

Commission plans to rush through regulations that ‘ensure Northern Ireland protocol remains unaffected’ Coronavirus – latest updates See all our coronavirus coverage Explainer: what is article 16 of the Northern Ireland protocol? Brussels will publish a revised regulation to potentially block vaccine exports out of the EU on Saturday, after an international outcry over its …

EU to publish revised rules after Covid vaccine border fiasco Read More »

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles

Pre-ordering of Janssen and Novavax means Britain has procured 247m successfully trialled jabs Coronavirus – latest updates See all our coronavirus coverage Britain has cemented its status as one of the world’s leading buyers of effective Covid vaccines after two more pharmaceutical companies reported positive trial results – potentially growing the UK stockpile by 90m …

UK vaccine strategy ‘paying off’ as latest trials boost stockpiles Read More »

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou

The shortfall in supply has put the EU and the UK at loggerheads, but ethical principles could reveal a solution In normal times, a row between the EU, the UK and a private company over the timely delivery of a contract would be of interest to few apart from the two sides’ lawyers. But these …

What can moral philosophy tell us about the Covid ‘vaccine nationalism’ row? | Alexis Papazoglou Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

How effective is the Novavax Covid vaccine and will it work against variants?

Everything you need to know about the trial results for a new coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage In an interim analysis of a phase 3 clinical trial conducted in the UK, the vaccine has been shown to be nearly 89% effective, with 27% of participants in the trial – …

How effective is the Novavax Covid vaccine and will it work against variants? Read More »

Novavax Covid vaccine shown to be nearly 90% effective in UK trial

UK vaccines taskforce has bought 60m doses after study found ‘spectacular results’ Coronavirus – latest updates See all our coronavirus coverage Another vaccine against Covid, trialled in the UK and bought by the government, has been shown to be nearly 90% effective and work against the UK and South African variants of the virus. The …

Novavax Covid vaccine shown to be nearly 90% effective in UK trial Read More »

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz

Slowness to sign up to and approve the vaccine may have caused delays, but Brussels feels the company is being less than cooperative Coronavirus – latest updates See all our coronavirus coverage Last year AstraZeneca was heralded for its pioneering vaccine discovery. Yet today the British-Swedish pharmaceutical company is embroiled in a dispute with the …

The EU’s vaccine bust-up with AstraZeneca is of its own making | Leo Cendrowicz Read More »

EU means business over Covid vaccine exports, says Von der Leyen

Commission president says firms must deliver on orders after AstraZeneca warns of shortfall Coronavirus – latest updates See all our coronavirus coverage The EU “means business”, Ursula von der Leyen has said, as the bloc doubled down on plans for tighter monitoring of vaccine exports to countries outside of the union, such as the UK. …

EU means business over Covid vaccine exports, says Von der Leyen Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

Vaccine experts call for clarity on UK’s 12-week Covid jab interval

British Society for Immunology calls for a robust programme monitoring the body’s immune response Experts have called for greater clarity on the monitoring in place to assess the 12-week dosing interval for Covid-19 vaccines, as the row over delayed second doses continues. The UK’s coronavirus vaccination programme was shifted late last year to prioritise administering …

Vaccine experts call for clarity on UK’s 12-week Covid jab interval Read More »

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet

Exactly a year after his first story about coronavirus, our science editor received the Pfizer injection last week. Here he reflects on a remarkable scientific achievement Coronavirus – latest updates See all our coronavirus coverage I marked a grim anniversary in an unexpected manner last week. On 18 January last year, I wrote my first …

I’ve had my first vaccine jab. It gives me hope of liberation… but not yet Read More »

Vaccine experts defend UK decision to delay second Pfizer Covid jab

Medics told they risk undermining public confidence by querying policy of three-month gap between doses Coronavirus – latest updates See all our coronavirus coverage Leading vaccine experts have backed the government’s decision to delay the second dose for up to three months, after doctors warned that the strategy was proving “ever-more difficult to justify”. The …

Vaccine experts defend UK decision to delay second Pfizer Covid jab Read More »

World’s poor need action, not Covid ‘vaccine nationalism’, say experts

Nations outbidding each other creates an ‘immoral race towards the abyss’ Coronavirus – latest updates See all our coronavirus coverage Pharmaceutical companies should do more to transfer vaccine technology to prevent the poorest countries falling behind in the distribution of Covid-19 vaccines, according to an expert. The warning came from Dag-Inge Ulstein, the co-chair of …

World’s poor need action, not Covid ‘vaccine nationalism’, say experts Read More »

MHRA and vaccine makers in talks over new Covid variants

Scientists start work on steps needed for potential rapid development of a modified vaccine, AstraZeneca says Coronavirus – latest updates See all our coronavirus coverage The UK medicines regulator is in discussions with coronavirus vaccine manufacturers about “potential modifications” that may be needed to ensure their jabs protect against new variants of the virus. The …

MHRA and vaccine makers in talks over new Covid variants Read More »

WHO platform for pharmaceutical firms unused since pandemic began

Exclusive: ‘pool’ to share Covid-19 information has received no contributions since May 2020 Coronavirus – latest updates See all our coronavirus coverage A World Health Organization program for pharmaceutical companies to voluntarily share Covid-19 related knowledge, treatments and technology so they can be more widely distributed has attracted zero contributions in the eight months since …

WHO platform for pharmaceutical firms unused since pandemic began Read More »

Single Covid vaccine dose in Israel ‘less effective than we hoped’

Surge in infections dampens optimism over country’s advanced immunisation programme Coronavirus – latest updates See all our coronavirus coverage Israel’s coronavirus tsar has warned that a single dose of the Pfizer/BioNtech vaccine may be providing less protection than originally hoped, as the country reported a record 10,000 new Covid infections on Monday. In remarks reported …

Single Covid vaccine dose in Israel ‘less effective than we hoped’ Read More »

Second shots of Covid vaccine could be delayed further in England

Evidence growing that spacing doses of Pfizer vaccine improves effectiveness Coronavirus – latest updates See all our coronavirus coverage Second shots of coronavirus vaccine could be delayed even further amid growing evidence that spacing out the doses improves their effectiveness. The NHS vaccination programme aims to immunise about 14 million people at greatest risk of …

Second shots of Covid vaccine could be delayed further in England Read More »

Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns

Australia has secured 54m doses of the vaccine some experts say is inferior to Pfizer’s mRNA vaccine, which Australia has bought just 10m doses of Covid hotspots Victoria; NSW hotspots; Queensland hotspots NSW and Sydney trend map: where cases are rising or falling Follow the Australia coronavirus live blog Australia’s chief medical officer Professor Paul …

Australia’s chief medical officer defends AstraZeneca’s Covid vaccine amid efficacy concerns Read More »

EU plans video summit after doubling supply of Pfizer Covid vaccine

Bloc agrees deal for a further 300m doses as hopes are raised for speedier rate of inoculations Coronavirus – latest updates See all our coronavirus coverage EU leaders are to hold a pandemic video summit on 21 January after the bloc said it had reached a deal with Pfizer and BioNTech for 300m more doses …

EU plans video summit after doubling supply of Pfizer Covid vaccine Read More »

Moderna Covid vaccine approved for use by UK medicines regulator

Britain’s third jab to receive clearance for public use will not be available until the spring Coronavirus – latest updates See all our coronavirus coverage The Moderna coronavirus vaccine has been approved for use in the UK. The jab is the third to be given the green light by the Medicines and Healthcare products Regulatory …

Moderna Covid vaccine approved for use by UK medicines regulator Read More »

Third Covid vaccine set for UK approval next week but arrival delayed by Brexit

Moderna jab won’t be available in Britain until April but fourth vaccine may soon come online Coronavirus – latest updates See all our coronavirus coverage A third Covid vaccine is likely to be approved for use in Britain next week but it will not be available until April because the UK is no longer part …

Third Covid vaccine set for UK approval next week but arrival delayed by Brexit Read More »

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty

The dire state of UK manufacturing has left us dependent on other nations. We may soon find out why some call this a ‘national security risk’ Everything now hinges on a vaccine: how many more Britons die, whether the NHS finally breaks, how long the UK stays locked down. All depends on how fast the …

Britain could be mass-producing its Covid shot. Shame we junked our industrial base | Aditya Chakrabortty Read More »

UK vaccine minister vows ‘massive uplift’ in number of jabs this week

Nadhim Zahawi says ‘absolute focus’ is to get 13.9 million people inoculated by mid-February Coronavirus – latest updates See all our coronavirus coverage The UK vaccine minister, Nadhim Zahawi, has pledged a “massive uplift” in the number of coronavirus vaccinations carried out this week as he said reaching the government’s target of 13.9m jabs offered …

UK vaccine minister vows ‘massive uplift’ in number of jabs this week Read More »

Centene to bolster behavioral health services with $2.2B Magellan Health acquisition

The insurer will pay $95 per share in cash to acquire Magellan Health, a company providing an array of services, including pharmacy benefit management and behavioral health and employee assistance program services. The companies aim to develop a behavioral health platform.

No data to support UK delay of vaccines’ second dose, says WHO

Move to postpone second jab by up to 12 weeks is not supported by scientific evidence, experts find Coronavirus – latest updates See all our coronavirus coverage There is no scientific evidence for a delay of more than six weeks in administering the second dose of the Pfizer/BioNTech vaccine against Covid, say experts from the …

No data to support UK delay of vaccines’ second dose, says WHO Read More »

Medical Writing Landscape Advancement Summit | Virtual

The Lincoln Health Network is excited to announce our 2nd Medical Writing Landscape Advancement Summit, March 3-4, 2021. Join us virtually, on the LHN virtual event platform to improve your medical writing strategies by understanding evolving regulatory protocols and submission guidelines, and learn how to improve quality and content optimizations. Visit our website for our …

Medical Writing Landscape Advancement Summit | Virtual Read More »

Analysis: is it wise for England to mix and match Covid vaccines?

US experts warn against plan to give different second jab if supplies run low Coronavirus – latest updates See all our coronavirus coverage The UK is setting the pace around the world in the approval and use of Covid vaccines but, while other countries watch intently, not all are yet prepared to embrace what looks …

Analysis: is it wise for England to mix and match Covid vaccines? Read More »

How is the Oxford Covid vaccine being deployed in England?

With jab to be administered to public for first time, we look at key questions about its rollout Coronavirus – latest updates See all our coronavirus coverage The biggest vaccination programme in the UK’s history will receive a major boost on Monday, with the first use of the Oxford/AstraZeneca Covid vaccine. We answer some key …

How is the Oxford Covid vaccine being deployed in England? Read More »

The Oxford Covid jab is delivered this week. But when will vaccines bring results?

Fall or rise in coronavirus cases will not initially be a good measure of efficacy, say scientists devising ways to audit progress Why is Britain delaying second doses of vaccine? Coronavirus – latest updates See all our coronavirus coverage People in Britain are set to get their first shots of the Oxford/AstraZeneca vaccine on Monday, …

The Oxford Covid jab is delivered this week. But when will vaccines bring results? Read More »

What difference will Oxford/AstraZeneca vaccine make in UK?

We look at how the introduction of a new vaccine in the fight against Covid will work Coronavirus – latest updates See all our coronavirus coverage The Oxford/AstraZeneca vaccine is central to the government’s plans for ending social distancing in the UK and returning to some sort of normality. It has invested in seven different …

What difference will Oxford/AstraZeneca vaccine make in UK? Read More »

Change in vaccine policy is a high-stakes gamble | Letters

The effectiveness of delaying the second dose of Covid vaccines must be carefully monitored, argues Dr Grizelda George, while Jan Mortimer and Jenny van Tinteren fear the move will increase distrust and uncertainty The manufacturer of the Pfizer/BioNTech vaccine has said its efficacy has only been assessed for two doses given three weeks apart. Therefore …

Change in vaccine policy is a high-stakes gamble | Letters Read More »

Questions hang over UK’s rollout of Oxford/AstraZeneca jab

Analysis: regulator surprises by approving 12-week gap between first and second shots of vaccine as well as Pfizer/BioNTech shot Coronavirus – latest updates See all our coronavirus coverage It’s a pragmatic solution to an incredibly urgent problem – how to immunise very large numbers of people at risk from a rampaging variant of Covid-19 in …

Questions hang over UK’s rollout of Oxford/AstraZeneca jab Read More »

Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health

Shots: Myovant & Pfizer will jointly develop & commercialize ORGOVYX (relugolix) in advanced prostate cancer & if approved, relugolix combination tablet in women’s health in the US & Canada. Myovant will receive ~$4.2B including $650M upfront, $200M in regulatory milestones for FDA approvals for relugolix combination tablet in women’s health, and tiered sales milestones upon …

Myovant Signs Agreement with Pfizer to Develop and Commercialize Relugolix in Oncology and Women’s Health Read More »

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant

Many medics ‘frustrated’ about low priority given to frontline staff at high risk of infection Coronavirus – latest updates See all our coronavirus coverage Frontline NHS staff have been denied the Pfizer/BioNTech vaccine, leaving doctors alarmed and “scrabbling” to get immunised. A new survey reveals that almost two-thirds of medics who responded to it have …

NHS doctors ‘scrabbling’ to get vaccine amid alarm at Covid variant Read More »

UK scientists trial drug to prevent coronavirus infection leading to disease

Exclusive: antibody therapy could confer instant immunity against Covid-19 to at-risk groups See all our coronavirus coverage British scientists are trialling a new drug that could prevent someone who has been exposed to coronavirus from going on to develop the disease Covid-19, which experts say could save many lives. The antibody therapy would confer instant …

UK scientists trial drug to prevent coronavirus infection leading to disease Read More »

Government ‘operated illegal buy British policy’ over Covid contracts

Other firms better placed to supply antibody tests, argues case against health secretary Matt Hancock Coronavirus – latest updates See all our coronavirus coverage The government was operating an illegal “buy British” policy when it signed contracts with a small UK firm to supply Covid antibody tests, claim lawyers who have filed a case against …

Government ‘operated illegal buy British policy’ over Covid contracts Read More »

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers

Pharmaceutical companies complain of breach of confidentiality after amount EU has agreed to pay for leading vaccines goes public Coronavirus – latest updates See all our coronavirus coverage A Belgian minister has inadvertently blown the lid off a sensitive and commercial secret – the price that the EU has agreed to pay for the leading …

Belgian minister tweets EU’s Covid vaccine price list to anger of manufacturers Read More »

Sandoz to Launch Hyrimoz (biosimilar, adalimumab) in Canada

Shots: Health Canada has authorized Hyrimoz on Nov 4, 2020 for marketing in Canada. Hyrimoz has been approved for use in all same indications as reference Humira, including rheumatology, gastroenterology and dermatology A patient support program will be available to patients treated with Hyrimoz providing guidance with reimbursement navigation, financial assistance, administrative support & education …

Sandoz to Launch Hyrimoz (biosimilar, adalimumab) in Canada Read More »

GSK/Sanofi Covid vaccine delayed until end of next year

Trials reveal vaccine failed to produce a strong immune response in older people Coronavirus – latest updates See all our coronavirus coverage A coronavirus vaccine being developed by GlaxoSmithKline and its French partner, Sanofi, will be delayed until the end of next year after trials revealed it failed to produce a strong immune response in …

GSK/Sanofi Covid vaccine delayed until end of next year Read More »

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi

The challenge of delivering vaccines on this scale are hard, but are firmly within the world of logistics, engineering, and politics Coronavirus – latest updates See all our coronavirus coverage The UK has become the first country to approve one of the coronavirus vaccines that the entire world has been desperately waiting for. And on …

Can the UK deliver on the Covid vaccine rollout? | Stephen Buranyi Read More »

Hackers accessed vaccine documents in cyber-attack on EMA

Papers relating to Pfizer/BioNTech vaccine reportedly targeted in attack on European Medicines Agency German biotech firm BioNTech said on Wednesday that regulation documents related to the Covid-19 vaccine it has developed with Pfizer were “unlawfully accessed” after a cyber-attack on Europe’s medicines regulator. Earlier, the European Medicines Agency (EMA) – which is responsible for assessing …

Hackers accessed vaccine documents in cyber-attack on EMA Read More »

Covid vaccine arrives in UK hospitals ready for first jabs

Medical director warns of great hurdles in largest vaccination campaign in UK history Coronavirus – latest updates See all our coronavirus coverage Batches of the Covid vaccine have begun to arrive in hospitals around the UK, ready for the first jabs on Tuesday in what NHS England’s medical director warned would be the largest and …

Covid vaccine arrives in UK hospitals ready for first jabs Read More »

Covid-19 vaccine ‘very safe and highly effective’, UK health chief says

Vaccine safety message ‘vitally important’, head of medicines regulator tells Andrew Marr Show Coronavirus – latest updates See all our coronavirus coverage Public health messaging that people can have faith in the safety of coronavirus vaccines is “vitally important”, the leader of the body that has approved the Pfizer jab has said. Dr June Raine, …

Covid-19 vaccine ‘very safe and highly effective’, UK health chief says Read More »

The vaccine miracle: how scientists waged the battle against Covid-19

We trace the extraordinary research effort, from the discovery of the virus’s structure to the start of inoculations this week Coronavirus – latest updates See all our coronavirus coverage In the early afternoon of 3 January this year, a small metal box was delivered to the Shanghai Public Health Clinical Centre addressed to virus expert …

The vaccine miracle: how scientists waged the battle against Covid-19 Read More »

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes

Shots: Abbott’s next-generation, sensor-based glucose monitoring technology, FreeStyle Libre 2, received Health Canada’s approval for adults & children with diabetes The system continuously measures glucose data every minute with customizable, optional real-time alarms to alert users when their glucose is high/low without scanning The technology sustains performance for ~14days, providing trends, insights & actionable data …

Abbott’s FreeStyle Libre 2 Receives Health Canada’s Approval for Adults and Children with Diabetes Read More »

Zoloft enters list of 10 most commonly prescribed drugs in Australia

Increase in women being diagnosed with depression partly behind rise in use An increase in women being diagnosed with depression is partly behind a significant rise in prescriptions of the antidepressant sertraline – sold under the brand name Zoloft – which is in the list of Australia’s most commonly prescribed drugs for the first time. …

Zoloft enters list of 10 most commonly prescribed drugs in Australia Read More »

Oxford controversy is the first shot in international battle over vaccine efficiency

Trials will not reveal all the facts on prevention for each new drug – that process could last for years Coronavirus – latest updates See all our coronavirus coverage In a few days, researchers plan to solve a medical mystery that threatens to erupt into a major transatlantic battle. Scientists at Oxford University say they …

Oxford controversy is the first shot in international battle over vaccine efficiency Read More »

Different age groups may get different Covid vaccines, experts say

Oxford/AstraZeneca planning new trial of lower-dose jab to see how well it works in older people Coronavirus – latest updates See all our coronavirus coverage Concerns around the efficacy of the Oxford University/AstraZeneca coronavirus jab in older people could lead to different age groups being given different vaccines, experts have said. The partners announced last …

Different age groups may get different Covid vaccines, experts say Read More »

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn

Pioneered by a Turkish-German couple, its significance exceeds its practical value The world took note when the German startup BioNTech announced its breakthrough in the development of a new type of vaccine to combat Covid-19. After testing tens of thousands of people, BioNTech’s vaccine has been shown to be 95% effective in providing protection for …

BioNTech’s Covid vaccine is a triumph of innovation and immigration | Hans-Werner Sinn Read More »

Will everyone in the world have access to a Covid vaccine? – video explainer

The hunt for a coronavirus vaccine is showing promise but it is premature to say the end of the pandemic is nigh. Several rich countries have signed a ‘frenzy of deals’ that could prevent many poor nations from getting access to immunisation until at least 2024. Also, many drug firms are potentially refusing to waive patents and other intellectual property rights …

Will everyone in the world have access to a Covid vaccine? – video explainer Read More »

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd

Do not demonise. To optimise the vaccine rollout, all of us must show respect to those who are unsure about inoculations Will Hanmer-Lloyd is a behavioural strategist The Covid-19 vaccines, which are up to 95% effective, have the potential to save millions of lives in the UK and many more around the world. Yet creating …

Here’s how to tackle the Covid-19 anti-vaxxers | Will Hanmer-Lloyd Read More »

A vaccine revolution | podcast

Results from clinical trials have shown that the world has three apparently highly effective vaccines for Covid-19. With the race now on for regulatory approval, production and distribution, is the end of the pandemic within reach? After a gruelling year of successive waves of Covid-19 infections and national lockdowns there has been a burst of …

A vaccine revolution | podcast Read More »

Vaccine results bring us a step closer to ending Covid, says Oxford scientist

Latest breakthrough comes as PM says he hopes most at-risk could be immunised by Easter Coronavirus – latest updates See all our coronavirus coverage The world is moving a step closer to ending the coronavirus pandemic, the scientist behind Britain’s first vaccine has declared, as Boris Johnson said he hoped the majority of those most …

Vaccine results bring us a step closer to ending Covid, says Oxford scientist Read More »

Oxford/AstraZeneca vaccine ‘likely first to be widely used in UK’

Experts say Pfizer/BioNTech product faces more logistical challenges and obstacles Coronavirus – latest updates See all our coronavirus coverage The Oxford vaccine is likely to be the first Covid jab that large numbers of Britons receive, despite Pfizer’s candidate already being analysed by the medicines regulators, experts say. The fact that the Oxford vaccine can …

Oxford/AstraZeneca vaccine ‘likely first to be widely used in UK’ Read More »

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data

Trial participants react to news that Oxford AstraZeneca Covid vaccine has up to 90% efficacy Coronavirus – latest updates See all our coronavirus coverage Dan McAteer describes his reaction more as a sense of relief than elation when his phone pinged on Monday morning with a push alert reporting that the Oxford AstraZeneca vaccine has …

‘It’s a great day’: Oxford coronavirus vaccine volunteers on trial data Read More »

Oxford AstraZeneca results open up Covid vaccine to developing countries

Jab can be kept in fridge and is part of global initiative to distribute doses at limited cost Coronavirus – latest updates See all our coronavirus coverage The efficacy of the Oxford University/AstraZeneca vaccine opens the way for a cheap and more easily transportable vaccine to be made available to some of the world’s poorest …

Oxford AstraZeneca results open up Covid vaccine to developing countries Read More »

Lilly’s Bamlanivimab (LY-CoV555) Receives Health Canada’s Interim Authorization as a Treatment for COVID-19

Shots: The authorization is based on P-II BLAZE-1 study assessing the efficacy and safety of bamlanivimab (700/2800/7000 mg) alone or in combination with a second Ab vs PBO for the treatment of symptomatic COVID-19 in the outpatient setting Results: reduction in viral load & rates of symptoms & hospitalization, frequency & types of AEs are …

Lilly’s Bamlanivimab (LY-CoV555) Receives Health Canada’s Interim Authorization as a Treatment for COVID-19 Read More »

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial

Plans for mass immunisation against Covid-19 are developing fast, but concerns must be addressed In the 1960s, academics studying rumours drew inspiration from epidemiology. They noted how such stories spread through communities, “infecting” some individuals while others seemed immune, and how more resistant populations could stop their spread. Their insights have in turn been taken …

The Guardian view on coronavirus and vaccine scepticism: time to act | Editorial Read More »

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn

No one knew whether mRNA technology would work against this virus – but it does. It’s an extraordinary moment for science Coronavirus – latest updates See all our coronavirus coverage The past few months have brought a number of scientific terms to public attention. We’ve had to digest R (a virus’s reproduction number) and PCR …

Do mRNA vaccines for Covid signal a new era in disease prevention? | Adam Finn Read More »

Trials to begin in UK for Covid antibody cocktail drug treatment

Scientists say jab could be used to protect those who cannot be given vaccines Coronavirus – latest updates See all our coronavirus coverage Major trials will begin this weekend of an antibody cocktail that scientists hope will protect people against Covid-19 and could be swiftly used in care homes or on cruise ships in the …

Trials to begin in UK for Covid antibody cocktail drug treatment Read More »

UK faces calls to drop opposition to patent-free Covid vaccines

Request will be made at WTO meeting in order to allow mass production of treatments Coronavirus – latest updates See all our coronavirus coverage The UK will be asked to reconsider its opposition to waiving intellectual property rights for Covid-19 vaccines and treatments at a World Trade Organization meeting on Friday, a move that would …

UK faces calls to drop opposition to patent-free Covid vaccines Read More »

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows

Among first 170 Covid cases in trial, eight had received vaccine and 162 were in placebo group Coronavirus – latest updates See all our coronavirus coverage The Pfizer/BioNTech vaccine against Covid-19 performs even better than previously thought, with 95% efficacy, equalling the early results from Moderna on Monday, according to an analysis of the final …

Pfizer Covid-19 vaccine has 95% efficacy and is safe, further analysis shows Read More »

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab

Phase 3 success rate of 95% for US firm’s treatment is promising for UK vaccine trial Coronavirus – latest updates See all our coronavirus coverage Hopes are rising for the Covid jab being developed by Oxford University, after Moderna became the second company to reveal impressive results from its vaccine trials. Interim results from phase …

Moderna vaccine’s effectiveness bodes well for Oxford/AstraZeneca jab Read More »

UK in ‘advanced discussions’ to buy Moderna Covid vaccine

Britain decided not to buy US vaccine and earliest it could be supplied to UK is spring 2021 Coronavirus – latest updates See all our coronavirus coverage The UK has not acquired the Moderna vaccine but is in “advanced discussions” to ensure British access, officials have said, while cautioning that no one in the UK …

UK in ‘advanced discussions’ to buy Moderna Covid vaccine Read More »

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff

To make vaccination work, we must reach out to the naturally cautious – a bigger proportion than you might assume Coronavirus – latest updates See all our coronavirus coverage Lydia Guthrie is not very daring by nature. A psychotherapist and mother of two from Oxford, she couldn’t be persuaded into bungee jumping for all the …

It’s the ‘vaccine hesitant’, not anti-vaxxers, who are troubling public health experts | Gaby Hinsliff Read More »

BioNTech vaccine scientist says jab could halve Covid transmission

Uğur Şahin ‘very confident’ vaccine candidate developed with Pfizer will cause big reduction in cases Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first potential Covid-19 vaccine to clear interim clinical trials says he is “very confident” the jab will reduce transmission of the disease, perhaps by 50%, resulting in …

BioNTech vaccine scientist says jab could halve Covid transmission Read More »

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik

Better to build social solidarity than to dismiss reluctance to be immunised as ignorance Coronavirus – latest updates See all our coronavirus coverage “If a strain as deadly as the 1918 influenza emerges and people’s hesitancy to get vaccinated remains at the level it is today, a debilitating and fatal disease will spread.” So wrote …

Vaccination hesitancy is about lack of trust. Compulsion is not the answer | Kenan Malik Read More »

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic

Exclusive: BioNTech’s CEO Uğur Şahin says he is confident vaccine can ‘bash the virus over the head’ Coronavirus – latest updates See all our coronavirus coverage The scientist behind the first Covid-19 vaccine to clear interim clinical trials says he is confident his product can “bash the virus over the head” and put an end …

Scientist behind BioNTech/Pfizer vaccine says it can end pandemic Read More »

The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones

The pharmaceutical industry has long made exorbitant profits by free-riding on research carried out by the public sector Hooray for Pfizer! As news of a vaccine potentially offering 90% protection against Covid-19 offers a life raft for lockdown-weary humanity, perhaps those home-drawn posters on people’s windows thanking the NHS will soon be applauding big pharma …

The Covid vaccine will benefit humanity – we should all own the patent | Owen Jones Read More »

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury

Despite the Pfizer breakthrough, social distancing and remote working won’t disappear overnight Coronavirus – latest updates See all our coronavirus coverage The news this week that the Pfizer/BioNTech vaccine protected more than 90% of recipients is of huge importance. The vaccine efficacy is higher than we had hoped for. There appear to be no safety …

Why a Covid vaccine doesn’t mean the end of face masks yet | David Salisbury Read More »

The Guardian view on the Covid vaccine breakthrough: making it work | Editorial

At last, there is hope of an end to this pandemic. Scientists appear to have performed an amazing feat, the rest of us must do our best too Medicine is only partly a matter of science; it is, very much, the business of people. The inspiring news that a Covid vaccine appears within reach, with …

The Guardian view on the Covid vaccine breakthrough: making it work | Editorial Read More »

Cautious optimism over Covid-19 vaccine trials | Letters

Readers respond to news that an interim analysis has shown Pfizer/BioNTech’s vaccine candidate was 90% effective in protecting people from transmission of the virus in global trials The media have been awash with stories about the apparent success of the Pfizer Covid vaccine following the publication of preliminary trial outcomes (Hopes rise for end of …

Cautious optimism over Covid-19 vaccine trials | Letters Read More »

6 key questions about the Pfizer/BioNTech Covid-19 vaccine

There are grounds for optimism but also several unknowns around this coronavirus vaccine Coronavirus – latest updates See all our coronavirus coverage Hopes that the end of the coronavirus pandemic has become nearer have soared after the news that a coronavirus vaccine was found to be 90% effective in global trials. Although there is definite …

6 key questions about the Pfizer/BioNTech Covid-19 vaccine Read More »

What does the Pfizer Covid vaccine breakthrough mean for Australia?

Interim results show vaccine to be 90% effective, but findings have not been peer-reviewed, Australia has only secured enough for five million people, and there are concerns around its storage temperature • Pfizer says vaccine is 90% effective • What has Pfizer’s vaccine trial found? • Vaccine announcement is cause for cautious celebration News that …

What does the Pfizer Covid vaccine breakthrough mean for Australia? Read More »

Pfizer/BioNTech vaccine announcement is cause for cautious celebration

Interim trial results are encouraging as scientists welcome news Coronavirus – latest updates See all our coronavirus coverage It is not yet the end of the pandemic, but the announcement by Pfizer/BioNTech that their vaccine has been 90% successful in the vital large-scale trials has got even the soberest of scientists excited. These are interim …

Pfizer/BioNTech vaccine announcement is cause for cautious celebration Read More »

What has Pfizer’s Covid vaccine trial found and is this a breakthrough?

Early results from phase 3 trial look promising but there are still many questions to be answered Coronavirus – latest updates See all our coronavirus coverage Pfizer and the German biotech company Biontech said on Monday that they had had encouraging early results from a phase 3 clinical trial of their coronavirus vaccine. The trial …

What has Pfizer’s Covid vaccine trial found and is this a breakthrough? Read More »

Oxford Covid vaccine works in all ages, trials suggest

Vaccine being trialled by Oxford University and AstraZeneca offers hope for all age groups Coronavirus – latest updates See all our coronavirus coverage One of the world’s leading Covid-19 experimental vaccines produces an immune response in both older and young adults, raising hopes of a path out of the gloom and economic destruction wrought by …

Oxford Covid vaccine works in all ages, trials suggest Read More »

Novartis’s Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease

Shots: Health Canada has approved Luxturna (voretigene neparvovec) as a one-time gene therapy for the treatment of adult & pediatric patients with vision loss due to inherited retinal dystrophy caused by confirmed biallelic RPE65 mutations and who have sufficient viable retinal cells Luxturna is designed to provide functioning copies of the RPE65 gene to act …

Novartis’s Luxturna (voretigene neparvovec) Receives Health Canada Approval as the First Gene Replacement Therapy for Inherited Retinal Disease Read More »

NHS coronavirus tests threatened by Roche supply chain glitch

Pharmaceutical firm reports ‘significant drop in processing capacity’ of reagents, kits and swabs Coronavirus – latest updates See all our coronavirus coverage Concerns have been raised over the supply of vital testing materials for a range of conditions, including Covid-19, following a supply chain problem with the pharmaceutical company Roche. On Tuesday, Roche said it …

NHS coronavirus tests threatened by Roche supply chain glitch Read More »

Trump’s steroid Covid treatment adds to confusion over health

Dexamethasone ‘normally reserved for people going into respiratory failure’, says expert Trump coronavirus treatment – live updates The latest intervention from Donald Trump’s medical team has been to put the president on dexamethasone, a steroid that is proven, thanks to the UK’s Recovery trial, to benefit Covid-19 patients who are having breathing difficulties. But the …

Trump’s steroid Covid treatment adds to confusion over health Read More »

UK doing more than most to help poor get Covid vaccine, study finds

Campaign scoring countries for global access efforts calls for more British transparency Coronavirus – latest updates See all our coronavirus coverage The UK is doing more than most countries to support access to Covid vaccines for the poorest populations in the world, but it is not transparent enough about the deals it is doing at …

UK doing more than most to help poor get Covid vaccine, study finds Read More »

Thalidomide survivors mourn Harold Evans, their hero and friend

Former Sunday Times editor’s genius and empathy will be missed, say campaigners At 5.39am on Thursday morning Guy Tweedy, a thalidomide survivor, campaigner and friend of Harold Evans, received an email from Tina Brown and Georgie and Izzy, the couple’s two children. Related: Sir Harold Evans – a life in pictures Continue reading…

Pharmacies in England pause online flu jab bookings as demand soars

Boots, LloydsPharmacy and Well Pharmacy report unprecedented take-up and many chemists run out of stock Coronavirus – latest updates See all our coronavirus coverage Pharmacies across England are struggling to keep up with the demand for the flu vaccine, pausing online bookings and limiting it to those most in need. The country’s three largest pharmacy …

Pharmacies in England pause online flu jab bookings as demand soars Read More »

Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes

Healthcare workers and health departments will be among the first to use the rapid antigen tests Full Australian Covid stats; Covid restrictions state by state Follow our global live blog Vic cases map; NSW cases map NSW hotspots list; Qld hotspots list Australia’s drugs regulator has approved four rapid antigen Covid-19 tests for distribution throughout …

Australia’s drug regulator TGA approves Covid tests that deliver results in 15 minutes Read More »

From the archives: How Boots went rogue – podcast

We are raiding the Audio Long Reads archives and bringing you some classic pieces from years past, with new introductions from the authors. This week’s article: Britain’s biggest pharmacy used to be a family business, dedicated to serving society. Now, many of the company’s own staff believe that its relentless drive for profit is putting …

From the archives: How Boots went rogue – podcast Read More »

Medical cannabis companies cleared for London stock market

Regulator agrees to float of UK firms but recreational suppliers still banned Medicinal cannabis companies have been cleared by the UK’s financial regulator to float on the London Stock Exchange but firms that sell marijuana to recreational users will still be banned. The Financial Conduct Authority said businesses that grow and sell recreational cannabis, even …

Medical cannabis companies cleared for London stock market Read More »

Beware of big pharma in rush for Covid-19 vaccine | Letter

Heidi Chow on why the pharmaceutical industry must not be left in the driving seat to supply an effective Covid-19 vaccine The biggest gamble that governments are taking is not on specific vaccine candidates, but on the pharmaceutical industry itself (The Covid-19 vaccine gamble: where bets have been placed and why, 11 September). The pharmaceutical …

Beware of big pharma in rush for Covid-19 vaccine | Letter Read More »

Oxford University resumes Covid-19 vaccine trials

Trials of vaccine being developed with AstraZeneca had been paused after participant fell ill Coronavirus – latest updates See all our coronavirus coverage The closely watched trial of an experimental Covid-19 vaccine that was halted after a participant fell ill is to resume in the UK. The University of Oxford, which has partnered with pharmaceutical …

Oxford University resumes Covid-19 vaccine trials Read More »

Show more empathy to boost confidence in vaccines, scientists told

Expert behind vaccine confidence report points to halting of Oxford Covid trial as example Doctors and scientists need to show more empathy towards volunteers in coronavirus vaccine trials who fall ill if the public is to have full confidence in the safety of the vaccines being developed, say experts. The temporary halting of the Oxford …

Show more empathy to boost confidence in vaccines, scientists told Read More »

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief

Pharmaceutical firm’s boss says 2020 deadline possible if regulators move fast Coronavirus – latest updates See all our coronavirus coverage AstraZeneca’s coronavirus vaccine could still be available by the end of the year, or early next year, according to the company’s chief executive, Pascal Soriot, despite clinical trials being paused after a volunteer fell ill. …

Oxford Covid-19 vaccine is still possible this year, says AstraZeneca chief Read More »

Oxford Covid vaccine trial suspension: what happens next?

Tests have been paused after a UK volunteer became ill. How will it affect the search for a cure? The AstraZeneca vaccine trial has been paused – should we be worried? Coronavirus – latest updates See all our coronavirus coverage One of the volunteers in the UK has become ill and it is crucial that …

Oxford Covid vaccine trial suspension: what happens next? Read More »

The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried?

Is this the end for hopes of an early breakthrough in the race to find a coronavirus drug? The halt in development of the University of Oxford’s Covid-19 vaccine due to a possible adverse reaction in a trial participant has triggered fears of a delay in finding a solution to coronavirus restrictions. A spokesman for …

The Oxford University AstraZeneca Covid-19 vaccine trial has been paused – should we be worried? Read More »

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant

A spokesman for AstraZeneca, the company working on the coronavirus vaccine, said pausing trials was common during vaccine development The development of a promising Covid-19 vaccine has been put on hold due to a possible adverse reaction in a trial participant. A spokesman for AstraZeneca, the company working with a team from Oxford University, told …

Oxford University Covid vaccine trial put on hold due to possible adverse reaction in participant Read More »

GSK and Sanofi to start human trials of potential Covid-19 vaccine

World’s largest vaccine makers to begin testing on people in US with eye on rollout in early 2021 Coronavirus – latest updates See all our coronavirus coverage GlaxoSmithKline and Sanofi are to start testing their protein-based Covid-19 vaccine on humans for the first time, following promising results in earlier studies. GSK, the world’s largest vaccine …

GSK and Sanofi to start human trials of potential Covid-19 vaccine Read More »

Social Detriments of Health Goes Beyond Just Healthcare

Health care or medical care is very important for health, but it can’t be the only criteria for determining health. In 1948, the WHO defined Health as a state of complete physical, mental and social well-being and not merely the absence of disease or infirmity. The definition is relevant however it didn’t address various factors that …

Social Detriments of Health Goes Beyond Just Healthcare Read More »

Six of the most promising treatments for Covid-19 so far

While a cure-all drug or therapy is a long way off, there have been some breakthroughs Many different drugs and therapies are being trialled and used on patients with Covid-19. There are some positive results, which may be beginning to bring the hospital death toll down, but there is still a long way to go …

Six of the most promising treatments for Covid-19 so far Read More »

Oxford University Covid-19 vaccine firm denies Trump talks

AstraZeneca says it has not discussed ‘emergency use authorisation’ with the US Coronavirus – latest updates See all our coronavirus coverage The company manufacturing the Oxford University coronavirus vaccine has denied it is in talks with the Trump administration about fast-tracking its vaccine for emergency use ahead of November’s presidential elections. With both Russia and …

Oxford University Covid-19 vaccine firm denies Trump talks Read More »

Here’s everything you need to know about the potential Oxford University Covid vaccine

The vaccine is designed to mimic the coronavirus and train the immune system to react if a person is later infected Sign up for Guardian Australia’s coronavirus email Download the free Guardian app to get the most important news notifications The vaccine developed and tested by a team at Oxford University is one of the …

Here’s everything you need to know about the potential Oxford University Covid vaccine Read More »

Honey better treatment for coughs and colds than antibiotics, study claims

Research suggests honey also more effective than many over-the-counter medicines Honey may be better than conventional treatments for coughs, blocked noses and sore throats, researchers have said. The substance is cheap, readily available, and has virtually no side-effects. Doctors can recommend it as a suitable alternative to antibiotics, which are often prescribed for such infections, …

Honey better treatment for coughs and colds than antibiotics, study claims Read More »

‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi

Russia is not the only country pursuing domestic politics over global cooperation in the fight against coronavirus We’re all waiting for a coronavirus vaccine, but when Russia announced earlier this week that it would be the first country to approve one, nobody rejoiced. Scientists pointed out clinical testing wasn’t complete, the vaccine had been tested …

‘Vaccine nationalism’ stands in the way of an end to the Covid-19 crisis | Stephen Buranyi Read More »

UK agrees deals for 90m doses of two potential coronavirus vaccines

Government secures early access to those being developed by Novavax and Janssen Coronavirus – latest updates See all our coronavirus coverage The UK government has reached agreements it says will give British citizens early access to 90m doses of two more potential Covid-19 vaccines. The vaccines are being developed by the US biotech company Novavax …

UK agrees deals for 90m doses of two potential coronavirus vaccines Read More »

Australia experiencing critical shortage of antidepressants, contraceptives and HRT

Reasons for shortages are often unclear and substitutes, which are not subsidised by PBS, are prohibitively expensive Australia is experiencing a critical shortage of key drugs including antidepressants, contraceptives and hormone replacement therapies, a situation that experts say highlights systemic problems with medicine supply in the country. Most of the shortages appear unrelated to coronavirus …

Australia experiencing critical shortage of antidepressants, contraceptives and HRT Read More »

UK warns drug firms to stockpile in case of Brexit disruption

Companies should ensure six weeks’ worth of drugs for end of transition period, DHSC says Pharmaceutical companies should stockpile six weeks’ worth of drugs to guard against disruption at the end of the Brexit transition period, the government has said. The Department of Health and Social Care (DHSC) has written to medicine suppliers advising them …

UK warns drug firms to stockpile in case of Brexit disruption Read More »

UK government orders halt to Randox Covid-19 tests over safety issues

Care homes and members of public told to immediately stop using firm’s kits Coronavirus – latest updates See all our coronavirus coverage The UK government has instructed care homes and members of the public to immediately stop using coronavirus testing kits produced by a healthcare firm after safety problems were discovered. Randox was awarded a …

UK government orders halt to Randox Covid-19 tests over safety issues Read More »

The Guardian view on a women’s health scandal: under the skin | Editorial

An official review of vaginal mesh and medicines in pregnancy reveals systemic weaknesses, and sexism too Greater openness about women’s bodies was one of the big themes of postwar feminism. Access to contraception and the right to terminate a pregnancy were crucial stepping stones on a path to liberation from a social order that for …

The Guardian view on a women’s health scandal: under the skin | Editorial Read More »

Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize

Cumberlege report is a damning reminder of how arrogant, intimidating doctors have suppressed their patients’ views Julia Cumberlege’s report into avoidable harm inflicted by the healthcare system exposes an institutional inability to listen to patients in general and women in particular. Her investigation into decades of failure batters the reputation of the NHS, professional bodies, …

Pelvic mesh scandal is what happens when men with power ignore women | Richard Vize Read More »

The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney

We need a public register to show if healthcare professionals are in the pay of industry – or more patients will suffer It was never “just women’s problems”. After decades of having their suffering dismissed, many patients will have been relieved about the publication of the Independent Medicines and Medical Devices Safety Review yesterday. Led …

The pelvic mesh scandal makes it clear: doctors must declare any funding | Margaret McCartney Read More »

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

With the NHS deal on Kaftrio, I’m likely to live longer. This is why swift access to novel treatments is so important It’s been 15 weeks since I went into isolation to shield from Covid-19 – having cystic fibrosis (CF) put me in the high-risk category. I had expected this year to be a write-off …

Thanks to a new drug for cystic fibrosis, I can plan a future I thought I’d never have | Isabelle Jani-Friend

Read More »

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Hydroxychloroquine and lopinavir/ritonavir not found to help patients in hospital Coronavirus – latest updates See all our coronavirus coverage The World Health Organization (WHO) said on Saturday that it was discontinuing its trials of the malaria drug hydroxychloroquine and combination HIV drug lopinavir/ritonavir for patients in hospital with Covid-19 after they failed to reduce mortality. …

WHO says trials show malaria and HIV drugs don’t cut Covid-19 hospital deaths

Read More »

US secures world stock of key Covid-19 drug remdesivir

No other country will be able to buy remdesivir, which can help recovery from Covid-19, for next three months at least Coronavirus – latest US updates Coronavirus – latest updates See all our coronavirus coverage The US has bought up virtually all the stocks for the next three months of one of the two drugs …

US secures world stock of key Covid-19 drug remdesivir Read More »

I believe Roundup gave me cancer. The Monsanto settlement is a slap in the face | Christine Sheppard

I have to inject myself with needles just to stay alive. Still, Bayer will continue to sell Roundup, and refused to label it as carcinogenic Last Wednesday was my 71st birthday, a low-key celebration in these Covid-19 times. Then I heard the news that the pharmaceutical conglomerate Bayer has offered a settlement to resolve several …

I believe Roundup gave me cancer. The Monsanto settlement is a slap in the face | Christine Sheppard Read More »

Australian drugmakers hit by critical shortages at height of pandemic, inquiry hears

Evidence given to parliamentary committee sparks new calls to develop national capability to manufacture medicines and key supplies Australian companies were “shocked” to experience price-gouging and had trouble accessing critical supplies to make medicines and personal protective equipment at the height of the pandemic, a parliamentary committee has been told. It has prompted fresh calls …

Australian drugmakers hit by critical shortages at height of pandemic, inquiry hears Read More »

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

Rich countries’ governments are putting all their trust in a marriage of markets and philanthropy called Gavi Vaccines for Covid-19 are coming. Billions of dollars are flowing in, over 100 efforts are under way, and at least 13 leading candidates are already being tested on humans. But how will these vaccines reach the poorest people …

How will the world’s poorest people get a coronavirus vaccine? | Achal Prabhala and Kate Elder

Read More »

‘The wondrous map’: how unlocking human DNA changed the course of science

Thanks to the success of the Human Genome Project, 20 years ago this week, scientists can track biology and disease at a molecular level Twenty years ago this week, an international group of scientists announced it had put together the first genetic blueprint of a human being. After 10 years of effort, the team – …

‘The wondrous map’: how unlocking human DNA changed the course of science Read More »

Demand for flu vaccine soars as countries plan for second Covid-19 wave

Manufacturers warn they will struggle to meet demand as governments seek to ease pressure on health services Coronavirus – latest updates See all our coronavirus coverage Fears of a second wave of coronavirus have sparked a global scramble for influenza shots from countries that hope to vaccinate great swathes of the population to reduce pressure …

Demand for flu vaccine soars as countries plan for second Covid-19 wave Read More »

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Richard Horton does not hold back in his criticism of the UK’s response to the pandemic and the medical establishment’s part in backing fatal government decisions Coronavirus – latest updates See all our coronavirus coverage There is a school of thought that says now is not the time to criticise the government and its scientific …

The Lancet’s editor: ‘The UK’s response to coronavirus is the greatest science policy failure for a generation’

Read More »

TEDMED 2020 Meetups

TEDMED Meetups, uniquely designed conversations, engage the entire TEDMED community to share their individual perspectives and voices to help improve humanity’s health. Read on to view some of the details of these captivating conversations taking place at TEDMED 2020. Meetup 1 Tuesday, March 3rd, 8:00 am- 8:45 am Climate and Culture, A Health Equity Conversation …

TEDMED 2020 Meetups Read More »

These insects carry enough bacteria to the cause

Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property, complete with a 30-seat screening room, a 100-seat amphitheater and …

These insects carry enough bacteria to the cause Read More »

Morning people may have the lower breast cancer risk

Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property, complete with a 30-seat screening room, a 100-seat amphitheater and …

Morning people may have the lower breast cancer risk Read More »

She bought the Home the full same year she married

Struggling to sell one multi-million dollar home currently on the market won’t stop actress and singer Jennifer Lopez from expanding her property collection. Lopez has reportedly added to her real estate holdings an eight-plus acre estate in Bel-Air anchored by a multi-level mansion. The property, complete with a 30-seat screening room, a 100-seat amphitheater and …

She bought the Home the full same year she married Read More »